Since RILP's neurological changes are typically irreversible and a curative strategy has yet to be defined, prevention is the best approach. Treating the primary cancer remains an obvious requirement, but lower levels of lumbar plexus<unk>  dosing will minimize or eliminate RILP. One method to reduce the lumbosacral plexus' dosing is to include it with other at-risk organs that get spared from<unk> . Key to prevention is resolving the lack of clinical evidence between<unk>  treatments and the onset of neurological problems. That relationship is hidden by RILP's low toxicity rate, the lack of a large monitored population size and the lack of data pooling across multiple institutions.
Radiation-induced lumbar plexopathy
Complex regional pain syndrome
Spinal disc herniation
Calpainopathy
Lumbar disc disease
Nerve compression syndrome
Degenerative disc disease
Vascular myelopathy